Whole-exome sequencing identified ERBB2 and ERBB3 mutation (including short-variant mutation and copy number amplification) at a frequency of 6.5%–11.5% in CRC, and patients with ERBB2/ERBB3 mutations exhibited poorer prognoses (23, 24). Here, ERBB2 is linked to colorectal carcinoma.